Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer

Apolipoprotein B mRNA editing enzyme catalytic polypeptide 3B (APOBEC3B) plays an important role in tumor mutagenesis. However, its clinical significance in gastric cancer (GC) remains largely unknown. We enrolled a total of 482 GC patients from Zhongshan Hospital, Fudan University for immunohistoch...

Full description

Bibliographic Details
Main Authors: Siyu Xia, Yun Gu, Haijian Zhang, Yuchao Fei, Yifan Cao, Hanji Fang, Jieti Wang, Chao Lin, Heng Zhang, He Li, Hongyong He, Jiejie Xu, Ruochen Li, Hao Liu, Weijuan Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:OncoImmunology
Subjects:
apobec3b
gastric cancer
immune evasion
adjuvant chemotherapy
prognosis
Online Access:http://dx.doi.org/10.1080/2162402X.2021.1975386

Internet

http://dx.doi.org/10.1080/2162402X.2021.1975386

Similar Items